Record Information |
---|
Version | 2.0 |
---|
Created at | 2023-10-04 14:57:28 UTC |
---|
Updated at | 2024-09-03 04:18:02 UTC |
---|
NP-MRD ID | NP0331904 |
---|
Natural Product DOI | https://doi.org/10.57994/1258 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | (+)-(6S) N-13-demethyldiscorhabdin U |
---|
Description | (+)-(6S) N-13-demethyldiscorhabdin U was first documented in 2023 (PMID: 37755087). |
---|
Structure | CSC1=CC(=O)C(Br)=C[C@]11C=CNC2=C1C1=[NH+]CCC3=CNC(=C13)C2=O InChI=1S/C19H14BrN3O2S/c1-26-12-6-11(24)10(20)7-19(12)3-5-22-17-14(19)15-13-9(2-4-21-15)8-23-16(13)18(17)25/h3,5-8,22-23H,2,4H2,1H3/p+1/t19-/m1/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C19H15BrN3O2S |
---|
Average Mass | 429.3100 Da |
---|
Monoisotopic Mass | 428.00629 Da |
---|
IUPAC Name | (1S)-3-bromo-6-(methylsulfanyl)-4,8'-dioxo-6',10',15'-triazaspiro[cyclohexane-1,3'-tetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadecane]-1'(15'),2,2'(7'),4',5,9'(16'),11'-heptaen-15'-ium |
---|
Traditional Name | (1S)-3-bromo-6-(methylsulfanyl)-4,8'-dioxo-6',10',15'-triazaspiro[cyclohexane-1,3'-tetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadecane]-1'(15'),2,2'(7'),4',5,9'(16'),11'-heptaen-15'-ium |
---|
CAS Registry Number | Not Available |
---|
SMILES | CSC1=CC(=O)C(Br)=C[C@]11C=CNC2=C1C1=[NH+]CCC3=CNC(=C13)C2=O |
---|
InChI Identifier | InChI=1S/C19H14BrN3O2S/c1-26-12-6-11(24)10(20)7-19(12)3-5-22-17-14(19)15-13-9(2-4-21-15)8-23-16(13)18(17)25/h3,5-8,22-23H,2,4H2,1H3/p+1/t19-/m1/s1 |
---|
InChI Key | XCVKIRRNAMQALM-LJQANCHMSA-O |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
HSQC NMR | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | maria.orfanoudaki@nih.gov | National Cancer Institute, MD, USA | Maria Orfanoudaki | 2024-05-03 | View Spectrum | COSY NMR | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | maria.orfanoudaki@nih.gov | National Cancer Institute, MD, USA | Maria Orfanoudaki | 2024-05-03 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | maria.orfanoudaki@nih.gov | National Cancer Institute, MD, USA | Maria Orfanoudaki | 2024-05-03 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | maria.orfanoudaki@nih.gov | National Cancer Institute, MD, USA | Maria Orfanoudaki | 2024-05-03 | View Spectrum |
| Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
| Chemical Shift Submissions |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 600.314502325, C2D6OS, simulated) | maria.orfanoudaki@nih.gov | National Cancer Institute, MD, USA | Maria Orfanoudaki | 2024-05-03 | View Spectrum | 2D NMR | [1H, 13C] NMR Spectrum (2D, 600 MHz, Methanol, simulated) | maria.orfanoudaki@nih.gov | National Cancer Institute, MD, USA | Maria Orfanoudaki | 2023-10-04 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, Methanol, simulated) | maria.orfanoudaki@nih.gov | National Cancer Institute, MD, USA | Maria Orfanoudaki | 2023-10-04 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, Methanol, simulated) | maria.orfanoudaki@nih.gov | National Cancer Institute, MD, USA | Maria Orfanoudaki | 2023-10-04 | View Spectrum |
| Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Classification | Not classified |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|